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1. Introduction 
Obesity is becoming more and more prevalent in the world and has many recognized 
impacts on different body systems. Chronic obstructive pulmonary disease (COPD) is also 
very common and affects different systems but mainly the respiratory system. Of particular 
interest to us is the impact of obesity on respiratory function in general and more 
specifically in COPD patients. 
The objectives of the chapter are to: 1) explore the different impacts of obesity on respiratory 
function in healthy and COPD patients; 2) to try to explain the impact of obesity on exercise 
tolerance and exercise dyspnea; and 3) the study the impact of obesity on the outcomes of a 
pulmonary rehabilitation program for COPD patients. 
2. Definition of obesity 
The definition of obesity is based on body mass index (BMI) which is the ratio of body mass 
in kilograms to the square of the height in meters. A person is overweight if BMI is between 
25 and 30 kg/m² and obese if BMI is over 30 kg/m² [5]. This definition, although being 
simple and easily applicable to everyday clinical contexts, is somewhat simplistic in the 
sense that it does not take into account either body mass distribution or fat vs. fat free mass. 
These variables have important impact on the respiratory physiology and on the chronic 
obstructive pulmonary disease (COPD). 
3. Epidemiology 
Overweight and obesity are very prevalent in western countries. For instance, in Canada, it 
is estimated that, in 2004, 23.1 % of adults were obese and 36.1 % were overweight, up from 
13.8 and 28.5 % respectively compared to 1979 [6]. This has led the scientific community to 
talk about this phenomenon in terms of “obesity epidemic”, since the condition has recently 
been recognized as a disease [7]. 
4. Effects of obesity on respiratory physiology at rest 
Obesity has many different effects on respiratory physiology at rest. These effects will be 
explained in more detail in the following text and are summarized in table 1. 
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Lung volumes 
Reduced functional residual capacity and 
expiratory reserve volume exponentially 
with increases in BMI. 
Total lung capacity and residual volume 
within normal limits. 
Respiratory system compliance 
Reduced compliance mainly due to  
extra upper body weight (abdomen  
and thorax) and breathing at lower 
volumes. 
Expiratory flows 
Airways narrowed and more reactive but 
no consistent influence of BMI on either 
FEV1 or FEV1/FVC ratio. 
Oxygenation 
Alveoar collapsing at the lung bases 
causing V/Q mismatch leading to chronic 
hypoxia. 
Worse during sleep. 
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 Oxygen comsuption and 
ventilation 
VO2, VCO2, and VE higher for any given 
workload due to higher metabolic cost of 
moving a heavier body mass and increased 
work of breathing. 
Lung volumes 
Dynamic hyperinflation that raises lung 
volumes to a more compliant zone. 
Dyspnea 
Dyspnea is increased at any given 
workload but is proportional to the 
increase of VE. 
Table 1. Summary of the effects of obesity on respiratory physiology at rest and during 
exercise.  
4.1 Lung volumes and respiratory mechanics 
The best described effect of obesity is the reduction of the end-expiratory lung volume  
and functional residual capacity [2,8]. End-expiratory lung volume is the volume left in the 
lung at the end of a normal expiration and under most circumstances. functional residual 
capacity is the resting respiratory system volume determined by the equilibrium of two 
opposing forces [9]; the elastic recoil of the lung which exerts a deflating effect and the 
elastic properties of the chest wall that tends to expand because its resting volume is higher 
than the functional residual capacity in healthy individuals [9]. In the obese subject, 
reduction of the resting respiratory system volume at functional residual capacity is caused 
by the extra weight of the thoracic wall and the abdomen which reduces significantly the 
respiratory system compliance [10]. There is an exponential relationship between BMI  
and both functional residual capacity and end-expiratory lung volume [2]. Total lung 
capacity and residual volume are relatively unaffected by obesity [11]. So, with a preserved 
total lung capacity and residual volume, decreased functional residual capacity has two 
physiologic corollaries: 1) decreased expiratory reserve volume and, 2) increased inspiratory 
capacity [1].  
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Fig. 1. Exponential relation between BMI and both functional residual capacity (FRC) and 
expiratory reserve volume (ERV). Shown on the functional residual capacity graph are the 
upper and lower limits of normal. Adapted from [2].  
Although airways are narrower and more reactive than normal weight subjects, both 
maximal ventilatory capacity and expiratory volumes are preserved in the obese subject. 
There is no consistent evidence of BMI influencing forced expiratory volume in 1 second 
(FEV1) or FEV1/forced vital capacity [12,13]. 
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4.2 Oxygenation 
As functional residual capacity gets lower, it draws near the residual volume so much 
that, in some subjects, each tidal volume breath results in alveolar collapsing at the lung 
bases. This creates ventilation perfusion mismatch and can lead to chronic hypoxemia 
[14]. This phenomenon is exacerbated during sleep but can also be observed during 
daytime [15]. 
4.3 Importance of body mass distribution 
Fat mass distribution is of paramount importance when considering the effects of obesity on 
respiratory physiology. Waist size and waist-to-hip ratio is more closely related to the 
previously described changes than BMI alone [16,17]. Studies using dual X-ray 
absorptiometry (DEXA) allowed establishing that upper body fat, as opposed to lower body 
fat, is linked to reductions of functional residual capacity and expiratory reserve volume 
[18]. This association was observed for thoracic as well as abdominal fat. It thus seems that 
upper body mass is the main determinant of the lower lung volumes observed in the obese 
subject and that, because of the interdependence of the thoracic and abdominal cavity in 
terms of volume and pressure, the location of fat mass within the upper body is not an 
important determinant of lung volumes. 
5. Effects of obesity on respiratory physiology during exercise 
5.1 Oxygen consumption 
Both oxygen consumption (VO2) and carbon dioxide production (VCO2) are increased for a 
given workload in the obese individual [3]. This higher metabolic expenditure is due to the 
higher energy demand caused by the extra body mass that obese subjects have to carry 
around. Also, decreased respiratory system compliance increases significantly the work of 
breathing [19]. Maximal exercise capacity in terms of VO2 is not affected and is even 
increased [20,21]. Actually, absolute VO2 tends to be higher with increasing BMI, but specific 
VO2 expressed as VO2/kg tends to be lower with increasing BMI. This effect of obesity on 
VO2 is particularly evident in weight baring activities. 
5.2 Lung volumes during exercise 
As already mentioned, obese patients’ tidal volume is very close to their residual volume at 
rest. During exercise however, functional residual capacity increases to normal levels 
allowing the expansion in tidal volume to accommodate the increasing ventilatory demand 
in a fashion that is similar to healthy subject. In contrast to patients with obstructive lung 
disease, the increase in functional residual capacity is not deleterious in obese individuals as 
it serves to restore normal physiology and places the respiratory system in a more compliant 
position [22]. 
5.3 Ventilation and dyspnea relationship 
For a given workload, obese subjects feel more dyspnea than non-obese subjects. However, 
the relationship between ventilation and dyspnea is unchanged [3]. Because of the increased 
metabolic cost associated with obesity, ventilation is higher for a given workload [3]. It thus 
seems that the higher perception of dyspnea in obese subjects is only a normal response to 
higher minute ventilation and that changes in respiratory mechanics and physiology do not 
really impact on subjective sensations. 
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Fig. 2. Expiratory flow volume curve of an obese woman compared to a lean one. At rest, 
respiration is performed at lower lung volumes but with increasing ventilation, expiratory 
patterns tend to be closer. Adapted [3].  
6. Effects of obesity on COPD 
6.1 How frequently obesity and COPD coexist in the same subject 
It was traditionally thought that COPD patients were less likely to be obese. The rationale 
was that systemic inflammation in the more advanced stages of disease would lead to 
cachexia [23] rather than overweight. However, in the most recent studies looking at the 
association of high BMI and COPD, approximately two thirds is overweight or obese [24]. 
6.2 Impact of obesity on survival 
A BMI below 21 kg/m² was shown to be a negative prognosis marker [25] while obesity 
appears to convey a survival advantage in COPD, as it is the case in other chronic disease 
[26]. However, data relating to this so called “obesity paradox”, whereby obesity seems 
beneficial on survival, is often biased because more obese patients tend to have less severe 
or less advanced disease. 
6.3 The main physiologic changes in COPD 
The main characteristics of COPD are limitation of expiratory flow and hyperinflation. At rest, 
FEV1 and the ratio of FEV1 to forced vital capacity are decreased while functional residual 
capacity, end-expiratory lung volume, total lung capacity and residual volume are elevated. 
The main consequence of lower expiratory flows is a limitation in maximal ventilatory capacity 
[27]. The consequence of higher functional residual capacity and residual volume is reduction in 
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the respiratory capacity (IC). The main pathophysiological reasons for these reduction in flows 
and elevated lung volumes are an increased airway resistance due to inflammation and mucus 
production and an increased lung compliance due to parenchymal destruction [28,29]. 
 
 
Fig. 3. Schematic representation of dynamic hyperinflation in a COPD subject. During 
exercise, rising lung volumes lead to a decreased inspiratory capacity and respiration occurs 
at higher lung volumes [4].  
During exercise, the lower inspiratory capacity constraints the expansion in tidal volume in 
such a way that the increased ventilatory demand is more dependent upon the progression of 
the respiratory rate. This breathing pattern characterized by a rapid and shallow breathing 
shortens expiration, preventing full expiration to occur [4]. The increased airway resistance 
also contributes to this phenomenon leading to gas retention and dynamic hyperinflation [30]. 
Because of dynamic hyperinflation, COPD subjects breathe at higher lung volumes during 
exercise (closer to total lung capacity), in a less compliant portion of the volume-pressure 
relationship of the respiratory system. Work of breathing is increased in this situation and 
the resulting tidal volume for a given respiratory effort is decreased, a phenomenon being 
referred to as neuro-mechanical uncoupling. The final results of these physiological 
abnormalities for the patients is increased dyspnea perception [31]. 
Another important systemic consequence of COPD is limb muscle atrophy which is 
observed especially in the more advanced stages of the disease [23,32]. Total as well as lower 
limb muscle mass is decreased leading to fatigue during exercise [33]. In fact, some COPD 
subjects are not primarily limited by dyspnea but by leg fatigue during exercise [34]. This 
symptom also contributes significantly to exercise intolerance in COPD [35]. 
6.4 Effect of obesity on COPD at rest 
Obesity and COPD have various influences on respiratory physiology, some are similar and 
some are opposite. 
The relationship between BMI and either functional residual capacity or expiratory reserve 
volume are not affected by the presence of airflow obstruction [1]. However, obese COPD 
patients are less hyperinflated compared to their lean counterparts [1]. Moreover, for a given 
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FEV1, IC is higher in obese subjects [2]. These changes seem beneficial to COPD subjects, 
counteracting some of the deleterious effects of the disease. However, as previously mentioned, 
oxygen consumption is higher for a given workload for obese subjects, leading to higher 
ventilatory demand. This increased in ventilatory requirement further stresses the respiratory 
system whose capacity is already reduced by the presence of airflow limitation [35]. 
 
 
Fig. 4. Lung volumes of an obese and a non-obese COPD subject. A : At rest, lung volumes 
are reduced in the obese subject. B : During exercise, dynamic hyperinflation is reduced in 
the obese subject although still present. Adapted from [1].  
6.5 Exercise tolerance of the obese patients with COPD 
The effects of obesity on exercise tolerance in patients with COPD have not been studied 
extensively. In one study, obese patients with COPD had higher exercise capacity and were 
less dyspneic for a given ventilation during cycling exercise [1]. These effects were felt to be 
related to lower operating lung volumes and reduced dynamic hyperinflation [3]. Other 
studies have reported marked decreases in exercise tolerance during a 6-minutes walking 
test [36] but not during a cycling endurance test [37] in obese patients with COPD. It thus 
appears that obese patients with COPD perform better when cycling than in weight bearing 
activities such as walking [35]. 
7. Effects of obesity of pulmonary rehabilitation 
7.1 Rehabilitation as a therapeutic intervention in COPD 
Pulmonary rehabilitation is a multidisciplinary intervention focusing on exercise training 
and patient education and self-management [38]. The exercise component is essential if the 
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goal of rehabilitation is to improve exercise tolerance and reduce dyspnea [39]. It is 
recommended for patients experiencing persisting symptoms despite maximal 
pharmacologic therapy [38]. Rehabilitation can be provided in an outpatient setting or at 
home, with comparable benefits on exercise tolerance, dyspnea, quality of life and 
exacerbations [40]. It is considered the most effective therapy to improve symptoms and 
quality of life in COPD [41,42]. 
7.2 Specific exercise limitations 
Obese patients with COPD entering a rehabilitation program typically have a reduced 
exercise tolerance. [24]. In one study, their cycling capacity was comparable to lean patients 
with COPD while their walking capacity was reduced. Walking is more representative of 
daily activities, so it is felt that patients with COPD subjects that are also obese are more 
limited than their non-obese counterparts. Obese patients with COPD usually show similar 
improvements in exercise capacity than non-obese although they are less likely to achieve 
clinically significant improvements during walking [24]. These observations are important 
because identifying obese patients as having specific exercise limitations can help tailoring 
the rehabilitation program to their specific needs. Although obesity is associated with more 
functional impairment, quality of life of obese COPD subjects is not different than their non 
obese counterparts and improves to a similar extent with rehabilitation [24]. The fact that 
obesity does not seems to alter quality of life may be related to the subjective nature of the 
quality of life measures and to chronic adaptation to obesity with the progressive avoidance 
of certain tasks that are more challenging to obese individuals. 
7.3 Good opportunity to adopt healthier lifestyles 
The fact that upon entering pulmonary rehabilitation, obese COPD patients have a reduced 
walking capacity suggests that weight loss could be beneficial to improve their functional 
status. Although never formally tested, this is a legitimate assumption. Pulmonary 
rehabilitation could be an ideal setting to help patients with COPD adopting a healthier 
lifestyle that will eventually lead to long lasting weight loss [38]. 
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